Cargando…

Effect of Chinese Herbal Compound LC09 on Patients With Capecitabine-Associated Hand-Foot Syndrome: A Randomized, Double-Blind, and Parallel-Controlled Trial

Background: LC09 is composed with 5 kinds of traditional Chinese herbal medicines (Astragalus membranaceus, flowers carthami, lithospermum, geranium wilfordii, and radix angelicae) which are used in China and developed over several thousand years. Aim: To assess the effectiveness and safety of herba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Ran, Wu, Xuefeng, Jia, Liqun, Lou, Yanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324898/ https://www.ncbi.nlm.nih.gov/pubmed/32597691 http://dx.doi.org/10.1177/1534735420928466

Ejemplares similares

Clinical study for external Chinese herbal medicine LC09 treating hand-foot skin reaction associated with the antitumor targeted drugs: Protocol for a prospective, randomized, controlled, double-blind, and monocentric clinical trial
por: Wang, Gui, et al.
Publicado: (2020)

HAND-FOOT SYNDROME DUE TO CAPECITABINE
por: Surjushe, Amar, et al.
Publicado: (2009)

HAND-FOOT SYNDROME DUE TO CAPECITABINE
por: Surjushe, Amar, et al.
Publicado: (2008)

Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study)
por: Santhosh, Akhil, et al.
Publicado: (2022)

Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?
por: Saif, Muhammad W, et al.
Publicado: (2016)

Hyperpigmentation with Capecitabine: Part of Hand-Foot Syndrome or a Separate Entity?
por: Caprez, Jennifer, et al.
Publicado: (2018)

Generalised Lichenoid Drug Eruption Accompanied by Hand-foot Syndrome Due to Capecitabine
por: Tamer, Funda, et al.
Publicado: (2018)

Hand-Foot Syndrome Presentation Post-Capecitabine Treatment in a Black Patient
por: Whorton, Allison E, et al.
Publicado: (2022)

Hand-foot syndrome caused by capecitabine: incidence, risk factors and the role of dermatological evaluation
por: de Queiroz, Marina Vieira Rodrigues, et al.
Publicado: (2022)

Hand-Foot Syndrome with Scleroderma-like Change Induced by the Oral Capecitabine: A Case Report
por: Lee, Sehe-Dong, et al.
Publicado: (2007)

Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients
por: Kayikci, Emel Emine, et al.
Publicado: (2020)

Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer
por: Dong, Si-Qi, et al.
Publicado: (2021)

Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome – A literature review()
por: Nascimento, Anna Danielly Almeida do, et al.
Publicado: (2023)

An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?
por: Vasudevan, Biju
Publicado: (2010)

Compliance and Effective Management of the Hand-Foot Syndrome in Colon Cancer Patients Receiving Capecitabine as Adjuvant Chemotherapy
por: Son, Hyun-Sook, et al.
Publicado: (2009)

Treatment of capecitabine-induced hand-foot syndrome using a topical retinoid: A case report
por: INOKUCHI, MASAFUMI, et al.
Publicado: (2014)

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer
por: Lin, Shaoyan, et al.
Publicado: (2019)

Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
por: Hiromoto, Shiori, et al.
Publicado: (2021)

Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine: A case report
por: Ahn, Ha Rim, et al.
Publicado: (2021)

Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer
por: Hofheinz, R-D, et al.
Publicado: (2012)

Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach
por: Schmulenson, Eduard, et al.
Publicado: (2020)

Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand‐foot syndrome
por: Watts, Katie, et al.
Publicado: (2022)

Herbal medicine foot bath for the treatment of diabetic peripheral neuropathy: protocol for a randomized, double-blind and controlled trial
por: Fan, Guanjie, et al.
Publicado: (2018)

The Efficacy and Safety of a Herbal Toothpaste in Reducing Gingivitis: A Double-Blind, Randomized, Placebo-Controlled, Parallel Allocation Clinical Trial
por: He, Jinfeng, et al.
Publicado: (2019)

Benign dermoscopic parallel ridge pattern in plantar hyperpigmentation due to capecitabine
por: Tognetti, Linda, et al.
Publicado: (2015)

Safety and efficacy of an herbal formulation in patients with renal calculi - A 28 week, randomized, double-blind, placebo-controlled, parallel group study
por: Patankar, Suresh B., et al.
Publicado: (2020)

Comparative Evaluation of Novel Herbal Rice Husk Mouthwash with Kidodent against Streptococcus mutans: A Parallel Double-blinded Randomized Control Trial
por: Havale, Raghavendra, et al.
Publicado: (2022)

Tramadol/paracetamol combination tablet for postoperative pain following ambulatory hand surgery: a double-blind, double-dummy, randomized, parallel-group trial
por: Rawal, Narinder, et al.
Publicado: (2011)

Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer
por: Zielinski, Christoph, et al.
Publicado: (2016)

Development of a New Tool to Assess the Quality of Life of Patients with Hand–Foot Syndrome Receiving Capecitabine-Based Therapy: A Pilot Study
por: Jagdish, Prathepa, et al.
Publicado: (2022)

Synergism of Chinese Herbal Medicine: Illustrated by Danshen Compound
por: Su, Xuefeng, et al.
Publicado: (2016)

Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)
por: Iimura, Yohei, et al.
Publicado: (2022)

The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial
por: Lee, Seunghoon, et al.
Publicado: (2018)

Allergens in Hand, Foot, and Hand–Foot Eczema: An Intercomparison by Patch Testing
por: Sahana, S, et al.
Publicado: (2021)

Compound mucocutaneous adverse effects of oral capecitabine in a patient
por: Pinto, Hyacinth Peter, et al.
Publicado: (2014)

Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study
por: Kaur, Ramanjot, et al.
Publicado: (2020)

Therapeutic Effect of Jinzhen Oral Liquid for Hand Foot and Mouth Disease: A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial
por: Liu, Jun, et al.
Publicado: (2014)

Fast Screening of Biomembrane-Permeable Compounds in Herbal Medicines Using Bubble-Generating Magnetic Liposomes Coupled with LC–MS
por: Gu, Xiaoting, et al.
Publicado: (2021)

First Case of Foot Drop Associated with Capecitabine in a Patient with Thymidylate Synthase Polymorphism
por: Wilks, Andrew B, et al.
Publicado: (2017)

Efficacy and safety of herbal medicine (Dangguijagyag-san) for primary dysmenorrhea: study protocol for a randomized, double-blind, placebo-controlled, parallel-group, multi-center trial
por: Woo, Hye Lin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jc98s4lrs5ibavj467g8vn33ed